RankingsLogo

Fortrea Holdings Inc.

Fortrea Holdings Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Fortrea Holdings Inc. operates as a holding company. The company, through its subsidiaries, provides Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions.

Ticker: FTRE

Humankind Value: $31.6 B

Revenue: $2.7 B

Market Cap: $566.8 M

Badge100_2025
Positive and negative impacts of companies graphic.

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Fortrea Holdings Inc. has earned a spot in our top 100. The greatest contributors to this positive outcome are Healthcare R&D ($19.4 B), Pharmaceuticals ($9.6 B), and Economic Value ($1.9 B). The value associated with Healthcare R&D and Pharmaceuticals includes the impact of an estimated 550,000 additional years lived by people worldwide. The Humankind Value of this company can improve with reductions in Biofuel Production (-$205.8 M) and Greenhouse Gases (-$191.8 M). Healthcare R&D, Pharmaceuticals, Economic Value, Biofuel Production, and Greenhouse Gases are mostly or entirely a result of supply-chain relationships. For this firm, supply chain partners increase an already positive Humankind Value.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings